https://www.avient.com/investor-center/news/avient-announces-fourth-quarter-and-full-year-2022-results
will provide additional details on its 2022 fourth quarter and full year performance and 2023 outlook during its webcast scheduled for
Webcast Details
For more information, visit https://www.avient.com.
https://www.avient.com/sites/default/files/2025-03/Q4 2024 Avient Webcast Slides w Non-GAAP.pdf
They use words such as "will," “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,”
“believe” and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. items, include statements relating to future actions; prospective changes in raw material costs,
product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and
environmental liabilities; and financial results.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• disruptions or inefficiencies in our supply chain, logistics, or operations;
• changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change;
• fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• demand for our products and services;
• production outages or material costs associated with scheduled or unscheduled maintenance programs;
• unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• information systems failures and cyberattacks;
• our ability to service our indebtedness and restrictions on our current and future operations due to our indebtedness;
• amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
• other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts, and any recessionary conditions; and
• other factors described in our Annual Report on Form 10-K under Item 1A, “Risk Factors.”
FX
• Driven by strong drug delivery
sales, new business wins in
building & construction and
consumer
• Higher sales and favorable mix
more than offset by variable
compensation reset resulting in
lower adjusted EBITDA
Copyright © .
2025 11
Specialty Engineered Materials - Q4 2024 performance
260
280
49
56
• Growth headlined by healthcare,
including engineered materials in
remote monitoring devices, as
well as composites for building &
construction, wind energy, and
defense applications
• Higher sales and favorable mix
contributed to adjusted EBITDA
growth which more than offset
unfavorable impact of variable
compensation
FY 2024
Copyright © .
2025 13
Color, Additives & Inks – full year 2024 performance
2,007
2,047
358
384
• Driven by new applications for
drug delivery and building &
construction as well as demand
recovery in packaging and
consumer
• Adjusted EBITDA margin
expansion driven by higher sales
and net price benefit
Adj.
17.8%
Adj.
18.7%
Copyright © .
2025 14
Specialty Engineered Materials – full year 2024 performance
1,138
1,197
224
249
• Growth headlined by strong
demand for applications in
defense end market and
composites used in building &
construction and engineered
materials used in healthcare
• Adjusted EBITDA margin
expansion driven by higher sales
and favorable mix
Adj.
19.7%
Adj.
20.8%
Copyright © .
2025 15
Avient full year 2024 performance vs. full year 2023
3,143
3,240
502
526
Adj.
https://www.avient.com/sites/default/files/2024-01/AVNT January IR Presentation_w Non-Gaap Recs.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• Changes in laws and regulations regarding plastics in jurisdictions where we conduct business;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• Our ability to achieve strategic objectives and successfully integrate acquisitions, including Avient Protective Materials (APM);
• An inability to raise or sustain prices for products or services;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and
• Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, any recessionary conditions, and terrorism or hostilities
Use of Non-GAAP Measures
This presentation includes the use of both GAAP (generally accepted accounting principles) and non-GAAP financial measures.
GUIDANCE
$800
$754
$128
$123
Sales Adjusted EBITDA
$0.56 $0.57
13
• Demand impacted by destocking
and cautious customer sentiment
• Positive net price benefit:
o CAI - Pricing flat and raw
material deflation
o SEM - Pricing flat with
unfavorable mix related to
healthcare, more than offset
with raw material deflation
• Cost reductions driven by Clariant
synergies and reduced
administrative costs
Q3 EBITDA BRIDGE
($ millions)
CAI:
Price / Mix -)
Deflation 22)
SEM:
Price / Mix (6)
Deflation 13)
Net Price Benefit 29)
Cost Reductions 13)
Wage Inflation (8)
FX 1)
Q3 2023 Actual $ 123)
Adjusted
EBITDA
Q3 2022 Pro Forma $ 137)
Demand (49)
14
2023 G U I DAN CE
Q4 2023 GUIDANCE VS.
Avient reflects 2023 adjusted EBITDA guidance of $500M and estimated run-rate CAPEX of $110M.
2023E (%)
27
78
89
83 80 78 74
86
79 76
67 66
55
50
(39)
Av
ie
nt
AV
PM FM
C C
Avient Specialty
Other Specialty /
MULTIPLE EXPANSION
Note: Avient reflects 2023 adjusted EBITDA guidance of $500M and closing share price of $41.57.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for the United Kingdom.pdf
If a present or future law, governmental
decree, order, regulation, or ruling under any existing or future
legislation prevents Seller from increasing or revising the price as
provided herein, or nullifies or reduces any price or price increase
hereunder, upon written notice from one to the other, Seller and
Buyer will attempt to identify mutually agreeable changes to
conform this contract with such law, decree, order, regulation, or
ruling.
Seller may change the price and/or
terms of delivery and shipment at any time up until delivery, except
where a written alternative pricing mechanism exists that is signed
by Seller.
Unless otherwise expressly agreed in
writing between the Buyer and the Seller, the purchase price for the
Product shall be exclusive of any value added tax (or equivalent or
similar taxes) and the Buyer shall pay the Seller the amount of value
added tax (or equivalent or similar taxes) chargeable on the supply
of the Product in addition to the purchase price.
https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for Finland.pdf
If a present or future law, governmental
decree, order, regulation, or ruling under any existing or future
legislation prevents Seller from increasing or revising the price as
provided herein, or nullifies or reduces any price or price increase
hereunder, upon written notice from one to the other, Seller and
Buyer will attempt to identify mutually agreeable changes to
conform this contract with such law, decree, order, regulation, or
ruling.
Seller may change the price and/or
terms of delivery and shipment at any time up until delivery, except
where a written alternative pricing mechanism exists that is signed
by Seller.
Unless
otherwise stated, all prices are in Euros.
https://www.avient.com/investor-center/news/polyone-completes-clariant-masterbatch-acquisition-announces-new-name-avient-corporation
The combined net purchase price is
Net Purchase Price
Net purchase price
https://www.avient.com/news/polyone-establishes-outdoor-high-performance-solutions-team
Our suite of polymer solutions and value-added services are a perfect match to deliver on the demands of this high performance market.”
PolyOne Corporation, with 2014 revenues of $3.8 billion, is a premier provider of specialized polymer materials, services and solutions.
To access PolyOne’s news library online, please visit http://www.polyone.com/news.
https://www.avient.com/news/colorants-and-additives-avient-sustainable-luxury-plastic-packaging-be-featured-luxe-pack-new-york
Avient will exhibit at the 20th annual LUXE PACK New York in booth E08, showcasing its range of solutions and services for sustainable luxury plastic packaging.
PCR Color Prediction Service – winner of the 2023 Re|focus Sustainable Innovation in Design Award and a finalist for the 2023 Plastics Recycling Show Europe (PRSE) Product Technology Innovation of the Year Award, this digital service supports PCR resin coloration by illustrating the color possibilities or limitations of certain PCR material before sample development to help simplify the overall decision-making process for brand owners and technical colorists.
For more information, visit https://www.avient.com.
https://www.avient.com/investor-center/news/polyone-expands-specialty-color-and-additives-expertise-acquisition-iqap-masterbatch
will implement its proven invest-to-grow approach to integration and customer service.
was the clear choice that best aligns with our vision and ideals for world-class innovation and customer service."
NYSE: POL) is a premier provider of specialized polymer materials, services and solutions.
https://www.avient.com/sites/default/files/2023-06/Terms and Conditions of Sale for the U.S.%5B17%5D.pdf
If a present or future law, governmental
decree, order, regulation, or ruling under any existing or future
legislation prevents Seller from increasing or revising the price as
provided herein, or nullifies or reduces any price or price increase
hereunder, upon written notice from one to the other, Seller and
Buyer will attempt to identify mutually agreeable changes to
conform this contract with such law, decree, order, regulation, or
ruling.
Seller may change the price and/or
terms of delivery and shipment at any time up until delivery, except
where a written alternative pricing mechanism exists that is signed
by Seller.
Buyer acknowledges and represents that it
is familiar with and shall strictly comply with all applicable laws and
regulations concerning the trade, export or re-export of products,
services, data or technology (“Items”), including the International
Traffic in Arms Regulations (ITAR), the Export Administration
Regulations (EAR) and the trade sanctions regulations administered
by the U.S.